A patient with an aggressive lymphoma

is prescribed a combination of two chemotherapeutic agents. Laboratory studies

show that some cancer cells are resistant to the first drug, while others are

sensitive. The combination therapy results in a much higher overall rate of

cancer cell death compared to either drug alone.

Which explanation best accounts for

the rationale behind using combination chemotherapy in this context?